Individually and in combination, vitamins improved glycemia, insulin resistance, and dyslipidemia (Table 1) via a decrease in hepatic NF-kβ signaling (Figure 3) and its activators (Tables 1 & 2 and Figures 1 &2). The gene discussed is NFKB1; the disease is metabolic syndrome.